4
Changes in Ownership
ENDONOVO THERAPEUTICS, INC. Filed Acc 0001645470-19-000016
CEO bought 46,500 shares at an average $0.02 ($966)
From the SEC's structured data for this filing
Trades in this filing
Collier Alan Brian · CEO
Table I: Non-derivative
13 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2019-02-27 | Purchase : show line 1 in the form | +5,000 | $0.02 | $99 | 21,648,123 | D |
| 2019-02-27 | Purchase : show line 2 in the form | +500 | $0.02 | $10 | 21,648,623 | D |
| 2019-02-27 | Purchase : show line 3 in the form | +450 | $0.02 | $9 | 21,649,073 | D |
| 2019-02-27 | Purchase : show line 4 in the form | +50 | $0.02 | $1 | 21,649,123 | D |
| 2019-02-27 | Purchase : show line 5 in the form | +500 | $0.02 | $10 | 21,649,623 | D |
| 2019-02-27 | Purchase : show line 6 in the form | +5,000 | $0.02 | $100 | 21,654,623 | D |
| 2019-02-27 | Purchase : show line 7 in the form | +5,000 | $0.02 | $106 | 21,659,623 | D |
| 2019-02-27 | Purchase : show line 8 in the form | +5,000 | $0.02 | $105 | 21,664,623 | D |
| Open-market purchases · 46,500 sh · avg $0.02 · $966 | ||||||
Loading xslF345X03/primary_doc.xml…